91探花

Find out why animals are not always ideal when studying potential treatments for diseases like Alzheimer's.

This piece covers what's different about our cell coding approach.

MP Anthony Browne visits 91探花's labs and offices to officially open facilities.

Episode 3 of our special three part mini-series.

America is seeing huge growth in Synthetic Biology 鈥� the UK must ensure it doesn鈥檛 miss out.

91探花's Founder and CEO Mark Kotter talks to Kurier about reprogramming cells for therapies.

Read about the Babraham Investor Conference 2021 focusing on early-stage and scale-up life science and med-tech companies.

This piece focuses on the promise of stem cells for cell therapies.